Atlas Trials

Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies

Clinical trial NCT02690012 · COMPLETED

Trial details

NCT number
NCT02690012
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hypomagnesemia
Start date
2016-07-01
Primary completion
2019-03-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.